MWA
GSK icon

Medallion Wealth Advisors’s GSK GSK Stock Holding History

Medallion Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
368
+280
+318% +$14.8K 0.01% 639
2026
Q1 		$4.86K Hold
88
– – ﹤0.01% 876
2025
Q4 		$4.32K Hold
88
– – ﹤0.01% 888
2025
Q3 		$3.8K Hold
88
– – ﹤0.01% 902
2025
Q2 		$3.43K Sell
88
-140
-61% -$5.35K ﹤0.01% 894
2025
Q1 		$8.63K Hold
228
– – ﹤0.01% 708
2024
Q4 		$7.71K Buy
+228
New +$8.21K ﹤0.01% 705

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Medallion Wealth Advisors's GSK Position: Q2 2026 in Review

Medallion Wealth Advisors increased its GSK (GSK) stake by 318% in Q2 2026, buying an estimated $14.8K and bringing the position to 368 shares worth $19.3K. The position accounts for 0.01% of the portfolio, ranked #639.

Medallion Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Medallion Wealth Advisors held 368 shares of GSK worth $19.3K as of Q2 2026.
  • Medallion Wealth Advisors bought 280 GSK shares in Q2 2026, an estimated $14.8K.
  • GSK made up 0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #639 holding.
  • Medallion Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.